Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth
GBI Research, July 2011, Pages: 118
Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth
Summary
GBI Research’s report, “Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth” provides key data, information and analysis on the global neurology devices market. The report provides market landscape, competitive landscape and market trends information on five neurology devices market categories – CSF management, neurosurgical products, neurostimulation devices, interventional neurology, and neurological diagnostic equipment. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape and a detailed analysis of the pipeline products in each category. The report also reviews details about important merger and acquisition deals that have taken place in the neurology devices market during the past four years. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Market size and company share data for five neurology devices market categories – CSF management, neurosurgical products, neurostimulation devices, interventional neurology, and neurological diagnostic equipment.
- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010 has been given for all categories.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the endoscopy devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading technologies.
- Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc, Integra LifeSciences Holdings Corporation, B. Braun Melsungen AG and Cadwell Laboratories, Inc.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the neurology devices market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next big thing in the neurology devices market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global neurology devices market and the factors shaping it.
1
1 4
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 10
2.1 GBI Research Guidance 10
3 Global Neurology Devices Market Characterization 11
3.1 Global Neurology Devices Market, Revenue ($m), 2003–2010 11
3.2 Global Neurology Devices Market, Revenue Forecast ($m), 2010–2017 12
3.3 Global Neurology Devices Market, Key Trends 13
3.3.1 Neurostimulation Devices Segment Holds Significant Potential for Venture Capitalists 13
3.3.2 Innovative Therapies to be a Mainstay in the Neurology Devices Market 13
3.3.3 Robotic Neurosurgery is Improving Accuracy at a Microscopic Level 14
3.3.4 Increasing Demand for Minimally Invasive Surgery is Positively Impacting the Interventional Neurology Market 15
3.4 Global Neurology Devices Market, Market Dynamics 15
3.4.1 Market Drivers 16
3.4.2 Market Restraints 17
3.5 Global Neurology Devices Market, Key Company Share (%), 2010 19
4 Global Neurology Devices Market - Category Analysis and Forecasts 20
4.1 Neurology Devices 20
4.2 CSF Management 20
4.2.1 CSF Management Market, Global, Revenue ($m), 2003–2010 21
4.2.2 CSF Management Market, Global, Revenue Forecast ($m), 2010–2017 22
4.2.3 CSF Management - Market Dynamics 23
4.2.4 Market Drivers 23
4.2.5 Market Restraints 24
4.2.6 CSF Management Market, Global, Company Share (%), 2010 25
4.3 Neurosurgical Products 26
4.3.1 Neurosurgical Products Market, Global, Revenue ($m), 2003–2010 26
4.3.2 Neurosurgical Products Market, Global, Revenue Forecast ($m), 2010–2017 27
4.3.3 Neurosurgical Products Market Dynamics 28
4.3.4 Market Drivers 28
4.3.5 Market Restraints 29
4.3.6 Neurosurgical Products Market, Global, Company Share (%), 2010 30
4.4 Neurostimulation Devices 31
4.4.1 Neurostimulation Devices Market, Global, Revenue ($m), 2003–2010 32
4.4.2 Neurostimulation Devices Market, Global, Revenue Forecasts ($m), 2010–2017 33
4.4.3 Neurostimulation Devices Market Dynamics 34
4.4.4 Market Drivers 35
4.4.5 Market Restraints 39
4.4.6 Neurostimulation Device Market, Global, Company Shares (%), 2010 40
4.4.7 Interventional Neurology Market, Global, Revenue ($m), 2003–2010 42
4.4.8 Interventional Neurology Market, Global, Revenue Forecasts ($m), 2010–2017 43
4.4.9 Interventional Neurology: Market Dynamics 44
4.4.10 Market Drivers 44
4.4.11 Market Restraints 45
4.4.12 Interventional Neurology Market, Global, Company Shares (%), 2010 46
4.4.13 Neurological Diagnostic Equipment Market, Global, Revenue ($m), 2003–2010 47
4.4.14 Neurological Diagnostic Equipment Market, Global, Revenue Forecasts ($m), 2010–2017 48
4.4.15 Neurological Diagnostic Equipment: Market Dynamics 49
4.4.16 Market Drivers 49
4.4.17 Market Restraints 50
4.4.18 Neurological Diagnostic Equipment Market, Global, Company Shares (%), 2010 51
5 Global Neurology Devices Market - Country Analysis and Forecasts 52
5.1 Neurology Devices Market: Cross Country Analysis 52
5.2 Revenue Forecasts, By Country, 2003-2017 53
5.2.1 Neurology Devices Market, the US, Revenue ($m), 2003–2010 53
5.2.2 Neurology Devices Market, the US, Revenue ($m), 2010–2017 54
5.2.3 Neurology Devices Market, Canada, Revenue ($m), 2003–2010 55
5.2.4 Neurology Devices Market, Canada, Revenue ($m), 2010–2017 56
5.2.5 Neurology Devices Market, the UK, Revenue ($m), 2003–2010 57
5.2.6 Neurology Devices Market, the UK, Revenue ($m), 2010–2017 58
5.2.7 Neurology Devices Market, Germany, Revenue ($m), 2003–2010 59
5.2.8 Neurology Devices Market, Germany, Revenue ($m), 2010–2017 60
5.2.9 Neurology Devices Market, France, Revenue ($m), 2003–2010 61
5.2.10 Neurology Devices Market, France, Revenue ($m), 2010–2017 62
5.2.11 Neurology Devices Market, Italy, Revenue ($m), 2003–2010 63
5.2.12 Neurology Devices Market, Italy, Revenue ($m), 2010–2017 64
5.2.13 Neurology Devices Market, Spain, Revenue ($m), 2003–2010 65
5.2.14 Neurology Devices Market, Spain, Revenue ($m), 2010–2017 66
5.2.15 Neurology Devices Market, Japan, Revenue ($m), 2003–2010 67
5.2.16 Neurology Devices Market, Japan, Revenue ($m), 2010–2017 68
5.2.17 Neurology Devices Market, China, Revenue ($m), 2003–2010 69
5.2.18 Neurology Devices Market, China, Revenue ($m), 2010–2017 70
5.2.19 Neurology Devices Market, India, Revenue ($m), 2003–2010 71
5.2.20 Neurology Devices Market, India, Revenue ($m), 2010–2017 72
5.2.21 Neurology Devices Market, Australia, Revenue ($m), 2003–2010 73
5.2.22 Neurology Devices Market, Australia, Revenue ($m), 2010–2017 74
5.2.23 Neurology Devices Market, Brazil, Revenue ($m), 2003–2010 75
5.2.24 Neurology Devices Market, Brazil, Revenue ($m), 2010–2017 76
6 Global Neurology Devices Market - Competitive Assessment 77
6.1 Neurology Devices Market Opportunities and Risk Evaluation 77
6.2 Medtronic, Inc. 79
6.2.1 Business Overview 80
6.2.2 Key Products 80
6.3 Boston Scientific Corporation (Neurovascular Portfolio Acquired by Stryker) 82
6.3.1 Business Overview 82
6.3.2 Key Products 82
6.4 St. Jude Medical, Inc 84
6.4.1 Business Overview 84
6.4.2 Key Products 85
6.5 Integra LifeSciences Holdings Corporation 86
6.5.1 Business Overview 86
6.5.2 Key Products 86
6.6 B. Braun Melsungen AG 89
6.6.1 Business Overview 89
6.7 Cadwell Laboratories, Inc. 90
6.7.1 Business Overview 90
6.7.2 Key Products 90
7 Global Neurology Devices Market - Product Pipeline Analysis 92
7.1 Neurology Devices - Pipeline Products Summary 92
7.2 Neurostimulation Devices 93
7.2.1 Neurostimulation Devices: List of Pipeline Products 93
7.2.2 Neurostimulation Devices: Profiles of Key Pipeline Products 98
7.3 Interventional Neurology 100
7.3.1 Interventional Neurology: List of Pipeline Products 100
7.3.2 Interventional Neurology: Profiles of Key Pipeline Products 102
7.4 Neurological Diagnostic Equipment 103
7.4.1 Neurological Diagnostic Equipment: List of Pipeline Products 103
7.4.2 Neurological Diagnostic Equipment - Profiles of Key Pipeline Products 105
7.5 Neurosurgical Products 106
7.5.1 Neurosurgical Products - List of Pipeline Products 106
7.5.2 Neurosurgical Products - Profiles of Key Pipeline Products 106
7.6 CSF Management 107
7.6.1 CSF Management - List of Pipeline Products 107
7.6.2 CSF Management - Profiles of Key Pipeline Products 107
8 Global Neurology Devices Market - Consolidation Landscape 108
8.1 Deals by Count, 2007-2010 108
8.2 Key Deals in 2007-2010 110
8.2.1 Johnson & Johnson Completes Acquisition of Micrus Endovascular 110
8.2.2 Covidien Completes Acquisition Of ev3 for $2.6 Billion 111
8.2.3 Medtronic Acquired NDI Medical 112
9 Appendix 113
9.1 Definitions 113
9.1.1 Neurology Devices 113
9.1.2 CSF Management 113
9.1.3 Interventional Neurology 113
9.1.4 Neurological Diagnostic Equipment 114
9.1.5 Neurostimulation Devices 114
9.1.6 Neurosurgical Products 115
9.2 Acronyms 115
9.3 Research Methodology 116
9.3.1 Secondary Research 116
9.3.2 Primary Research 117
9.3.3 Modeling and Forecasting 117
9.4 Contact Us 117
9.5 Disclaimer 117
9.6 Sources 118
GBI Research’s report, “Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth” provides key data, information and analysis on the global neurology devices market. The report provides market landscape, competitive landscape and market trends information on five neurology devices market categories – CSF management, neurosurgical products, neurostimulation devices, interventional neurology, and neurological diagnostic equipment. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape and a detailed analysis of the pipeline products in each category. The report also reviews details about important merger and acquisition deals that have taken place in the neurology devices market during the past four years. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
Global Neurology Devices Market is forecast to reach $7.2 Billion by 2017
Neurology Devices Market, Global, Overall Revenues ($bn), 2010–2017
Source: GBI Research, Company Annual Reports and Interviews with Industry Experts and Key Opinion Leaders
The global market for neurology devices is forecast to reach $7.2 billion by 2017 with a Compound Annual Growth Rate (CAGR) of 10.4% from 2010-2017. Neurostimulation devices will remain the largest segment in the market with a value of $4.7 billion by 2017. The market is expected to be driven during the period 2010-2017 by the large patient pool suffering from neurological disorders such as epilepsy, Alzheimer’s disease, migraine, Parkinson’s syndrome, and chronic pain. Compelling clinical needs and expanding research activities on the central nervous system (CNS) will also accelerate technological innovations in neurostimulation devices and interventional neurology. Moreover, a lack of satisfaction with the first line of treatment drugs for neurological disorders will lead to increased adoption rates of neurology devices.
According to the Parkinson's disease Foundation, Parkinson’s disease affects more than one million people in the US and more than four million people worldwide as of 2010. Out of these three million patients, around one third of patients does not respond to current treatment options and continue to experience seizures. The huge patient population affected by various neurological disorders presents huge growth opportunities for the market in the future. Moreover, there is an increased preference among patients for minimally invasive procedures which cause fewer traumas to tissues and provides a faster recovery period. This trend can be seen across the US and Europe and will boost the neurology device market. In emerging countries such as Brazil, China and India, the focus is on improving healthcare facilities through the construction of new hospitals. This will provide access to healthcare for a larger population, increasing procedure volumes for minimally invasive surgery. Increasing patient awareness and a high incidence of neurological diseases in the elderly population will lead to an increase in demand for neurology devices. Furthermore, change in lifestyle and increasing income levels of patients across emerging countries is expected to drive the market for neurology devices.
Medtronic, Inc.
Boston Scientific Corporation (Neurovascular Portfolio Acquired by Stryker)
St. Jude Medical, Inc
Integra LifeSciences Holdings Corporation
B. Braun Melsungen AG
Cadwell Laboratories, Inc.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW6
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network